Gilead has gotten a new HIV preventive treatment, Yeztugo, approved, which consists of two injections a year, promising more effective prevention.
Lara Maior
Current Affairs
Foto Gilead Pharma
Always see our news on Google
Yeztugo, a drug developed by Gilead, has been authorized in the United States as a preventive treatment against HIV. It requires only two injections a year, unlike current treatments that require daily pills. While the treatment could revolutionize the fight against the AIDS epidemic, cost remains a crucial issue, with an estimated annual price tag of about $25,000. UNAIDS director Winnie Byanyima emphasized the importance of making the drug affordable to have a real impact in the fight against AIDS.
Sources
Tratament promiţător împotriva HIV-SIDA. Producătorii promit prețuri accesibil
Statele Unite autorizează un nou tratament preventiv, foarte promiţător, împotriva HIV, virusul care cauzează SIDA
FDA approves first twice-yearly injection that prevents HIV infection
US approves promising preventive HIV treatment
Groundbreaking twice-a-year HIV drug that could stop transmission approved
Latest News
08:02
Nazare: Romania passes the Fitch test at the limit and remains in the recommended investment category
07:40
Five people, including two minors, accused of terrorism in France
07:20
Fitch maintains Romania's rating at BBB-. The country avoids downgrade to 'junk' status.
23:14
The mayor of Iași announced the cessation of street lighting at night due to the energy crisis. The measure will save approximately 10 MWh per night.
22:41
A SpaceX rocket out of control will crash on the Moon, forming a 27-meter crater.
See more news
NEWS ON THE SAME TOPICS
.webp)
.webp)
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
